Harrow (HROW) to Release Earnings on Wednesday

Harrow (NASDAQ:HROW) is scheduled to post its quarterly earnings results after the market closes on Wednesday, November 13th. Analysts expect Harrow to post earnings of ($0.05) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Harrow (NASDAQ:HROW) last issued its earnings results on Wednesday, August 7th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.12. Harrow had a negative return on equity of 40.59% and a negative net margin of 21.78%. The business had revenue of $48.94 million during the quarter, compared to the consensus estimate of $42.78 million. On average, analysts expect Harrow to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Harrow Price Performance

Harrow stock opened at $45.80 on Wednesday. The stock’s 50 day moving average price is $46.53 and its 200 day moving average price is $30.45. Harrow has a 1-year low of $7.60 and a 1-year high of $59.23. The company has a debt-to-equity ratio of 3.18, a quick ratio of 2.43 and a current ratio of 2.60.

Analyst Upgrades and Downgrades

HROW has been the topic of several research analyst reports. Craig Hallum boosted their target price on shares of Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, October 4th. Lake Street Capital boosted their price objective on shares of Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, October 4th. Finally, B. Riley reaffirmed a “buy” rating and issued a $50.00 target price on shares of Harrow in a report on Thursday, August 29th.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.